Upregulated Expression of ERBB2/HER2 in Multiple Myeloma as a Predictor of Poor Survival Outcomes

The main goal of the present study was to examine if the RNA-sequencing (RNAseq)-based ERBB2/HER2 expression level in malignant plasma cells from multiple myeloma (MM) patients has clinical significance for treatment outcomes and survival. We examined the relationship between the RNAseq-based ERBB2...

Descripción completa

Detalles Bibliográficos
Autores principales: Uckun, Fatih M., Qazi, Sanjive
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298070/
https://www.ncbi.nlm.nih.gov/pubmed/37373090
http://dx.doi.org/10.3390/ijms24129943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298070/
https://www.ncbi.nlm.nih.gov/pubmed/37373090
http://dx.doi.org/10.3390/ijms24129943

Ejemplares similares